March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get basic information about viral load – what it is, when to have it tested, and how the results are used – and sex differences in viral load.
Get some great tips about traveling with HIV. Learn about packing your pills, adjusting your dosing schedule, and traveling abroad.